These are the two biggest companies in the cholesterol segment, companies with combined annual revenues of $12 billion, and (the guidelines) could add a couple of billion to each company over five years.

If the generic doesn't get out there then the pharmaceutical company (with the patent) obviously benefits.

Merck is not dumb. They're not in the business of losing money.

The more the two companies discussed co-heads, the more difficult it became.

I don't like to hurry. I'm not a conductor of the fast, fiery romantic type. I prefer Bruckner, with the sincerity of his musical language and the huge time spans in which his ideas develop, to Mahler, with his hysteria and self-indulgence.

God has not only given us strength and wisdom, but also the thought of perseverance and determination that makes us stronger when the going gets tough.